Interruption of natalizumab therapy for multiple sclerosis: What are the risks?

Robert T. Naismith, Dennis Bourdette

Research output: Contribution to journalEditorial

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)1854-1855
Number of pages2
JournalNeurology
Volume76
Issue number22
DOIs
StatePublished - May 31 2011

ASJC Scopus subject areas

  • Clinical Neurology

Cite this